Accelerated Resolution Therapy for Early Maladaptive Grief
ConditionGrief
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorMayo Clinic
About this trial
The purpose study is to test the effects of accelerated resolution therapy (ART) on pre-loss grief and prolonged grief disorder among older adult family caregivers (FCGs). Additionally, to better understand predictors of response to ART, and cognitive processes that occur among grieving individuals following ART.
Eligibility criteria
Qualifiers
Primary caregiver of immediate family member who has a life expectancy of less than 12 months
Score of 30 or higher on the PG-12-R, indicating clinically significant pre-loss grief
Denial of suicidal ideation or intent, with no evidence of psychotic behavior.
Disqualifiers
Since becoming a family caregiver (FCG), they have engaged in another trauma based psychotherapeutic regimen (EMDR, prolonged exposure therapy, trauma focused cognitive behavioral therapy) that could influence response to accelerated resolution therapy (ART).
Self-reported or clinically assessed major psychiatric disorder (e.g., bipolar disorder, schizophrenia).
Score of > 2 on the adapted CAGE questionnaire indicating alcohol /drug dependence.
Cognitive impairment (SPMSQ > 4 errors).
Trial design
Treatments tested in this trial
- Accelerated Resolution Therapy
- Information and Support
Treatment groups
440 Participants
are divided into 2 treatment groupsSponsors and collaborators
Mayo Clinic
Lead sponsor
National Institute on Aging (NIA)
Collaborator
Source ClinicalTrials.gov